Mauna Kea Technologies SAS (MKEA):企業の財務・戦略的SWOT分析

◆英語タイトル:Mauna Kea Technologies SAS (MKEA) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDME47989FSA
◆発行会社(調査会社):GlobalData
◆発行日:2021年4月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:フランス
◆産業分野:Medical Devices
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD600 ⇒換算¥88,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD900 ⇒換算¥133,200見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Mauna Kea Technologies SAS (MKT) is an endomicroscopy device manufacturer. The company develops, manufactures and distributes tools to visualize and detect cellular abnormalities during endoscopic procedures. It provides confocal laser endomicroscopy platform. MKT’s cellvizio is an endomicroscopy platform that provides microscopic images of tissue instantaneously and in a minimally-invasive way. The company also offers vasculature and vasodynamics studies, longitudinal monitoring of disease progression and in vivo histology. It provides technical support and training. MKT’s products are used for treatment of digestive diseases chronic acid reflux, pancreatic cysts , gastric disease and diagnosing respiratory diseases and also used in laboratories for research on small animals. The company has presence in North America, Europe and Asia. MKT is headquartered in Paris, France.

Mauna Kea Technologies SAS Key Recent Developments

Jan 21,2021: Mauna Kea Technologies reports fourth quarter and full year 2020 sales
Jan 06,2021: Mauna Kea Technologies reports preliminary fourth quarter 2020 sales
Dec 17,2020: Mauna Kea Technologies welcomes Jacquelien Ten Dam to board of directors
Sep 22,2020: Mauna Kea Technologies reports full financial results for first half of 2020 and preliminary third quarter of 2020 sales
Jul 23,2020: Mauna Kea Technologies appoints Claire Biot, Ph.D. to Board of Directors

This comprehensive SWOT profile of Mauna Kea Technologies SAS provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Mauna Kea Technologies SAS including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

【レポートの目次】

Table of Contents

Section 1 – About the Company

Mauna Kea Technologies SAS – Key Information
Mauna Kea Technologies SAS – Overview
Mauna Kea Technologies SAS – Key Employees
Mauna Kea Technologies SAS – Key Employee Biographies
Mauna Kea Technologies SAS – Key Operational Heads
Mauna Kea Technologies SAS – Major Products and Services
Mauna Kea Technologies SAS – History
Mauna Kea Technologies SAS – Company Statement
Mauna Kea Technologies SAS – Locations And Subsidiaries
Mauna Kea Technologies SAS
Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

Mauna Kea Technologies SAS – Business Description
Mauna Kea Technologies SAS – Corporate Strategy
Mauna Kea Technologies SAS – SWOT Analysis
SWOT Analysis – Overview
Mauna Kea Technologies SAS – Strengths
Mauna Kea Technologies SAS – Weaknesses
Mauna Kea Technologies SAS – Opportunities
Mauna Kea Technologies SAS – Threats
Mauna Kea Technologies SAS – Key Competitors

Section 3 – Company Financial Performance Charts

Mauna Kea Technologies SAS – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

Mauna Kea Technologies SAS, Key Information
Mauna Kea Technologies SAS, Key Ratios
Mauna Kea Technologies SAS, Share Data
Mauna Kea Technologies SAS, Major Products and Services
Mauna Kea Technologies SAS, History
Mauna Kea Technologies SAS, Key Employees
Mauna Kea Technologies SAS, Key Employee Biographies
Mauna Kea Technologies SAS, Key Operational Heads
Mauna Kea Technologies SAS, Other Locations
Mauna Kea Technologies SAS, Subsidiaries
Mauna Kea Technologies SAS, Key Competitors
Mauna Kea Technologies SAS, SWOT Analysis
Mauna Kea Technologies SAS, Ratios based on current share price
Mauna Kea Technologies SAS, Annual Ratios
Mauna Kea Technologies SAS, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[Mauna Kea Technologies SAS (MKEA):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Weizmann Institute of Science:製薬・医療:M&Aディール及び事業提携情報
    Summary Weizmann Institute of Science (WIS) is a research institute that offers research activities in the field of natural and exact sciences. The institute provides programs that include graduate programs, post graduate programs, scientific research, academic affairs, science education, research a …
  • Editas Medicine Inc (EDIT):企業の財務・戦略的SWOT分析
    Editas Medicine Inc (EDIT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Tatry Mountain Resorts, AS:戦略・SWOT・企業財務分析
    Tatry Mountain Resorts, AS - Strategy, SWOT and Corporate Finance Report Summary Tatry Mountain Resorts, AS - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Experian PLC (EXPN):企業の財務・戦略的SWOT分析
    Experian PLC (EXPN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Aker Solutions ASA (AKSO):石油・ガス:M&Aディール及び事業提携情報
    Summary Aker Solutions ASA (Aker Solutions) is a global provider of engineering, design, production systems and services to the oil and gas industry. The company offers subsea production equipment and offshore field design, ranging from concept studies and front-end engineering to subsea production …
  • Choppies Enterprises Limited (CHOPPIES):企業の財務・戦略的SWOT分析
    Choppies Enterprises Limited (CHOPPIES) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • Sichuan Kelun Pharmaceutical Co Ltd (002422):医療機器:M&Aディール及び事業提携情報
    Summary Sichuan Kelun Pharmaceutical Co., Ltd. (Kelun) is engaged in manufacturing and distribution of IV Solutions. The company’s products portfolio includes glucose injection, sodium chloride injection, glucose and sodium chloride injection, ringer’s injection, lactated ringer’s injection, compoun …
  • Voyager Therapeutics Inc (VYGR):企業の財務・戦略的SWOT分析
    Summary Voyager Therapeutics Inc (Voyager) is a clinical-stage gene therapy company that develops treatments for patients suffering from severe neurological diseases. The company provides treatment for adeno-associated virus gene therapy field by selecting, designing and manufacturing vectors. Its c …
  • Volkswagen Financial Services AG:企業の戦略・SWOT・財務情報
    Volkswagen Financial Services AG - Strategy, SWOT and Corporate Finance Report Summary Volkswagen Financial Services AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • UNeMed Corp-医療機器分野:企業M&A・提携分析
    Summary UNeMed Corp (UneMed), a subsidiary of University of Nebraska Medical Center is a healthcare service provider that offers technology transfer and commercialization services. The company offers services such as inventions, material transfer, confidentiality, intellectual property, startup form …
  • DocCheck AG (AJ91):企業の財務・戦略的SWOT分析
    DocCheck AG (AJ91) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Oscotec Inc (039200):企業の財務・戦略的SWOT分析
    Summary Oscotec Inc (Oscotec) is a biotechnology company which discovers and develops drugs for cancer treatments. The company’s pipeline products include SKI-O-703, a spleen tyrosine kinase (SYK) inhibitor, against rheumatoid arthritis and idiopathic thrombocytopenic purpura; lazertinib (GNS-1480 Y …
  • Eyevensys SAS:製薬・医療:M&Aディール及び事業提携情報
    Summary Eyevensys SAS (Eyevensys) is a clinical stage biotechnology company developing non-viral gene therapies for ophthalmic diseases. Its lead product, EYS-606, is a soluble TNFa receptor plasmid associated with the ETIS device to treat non-infectious intermediate and posterior uveitis(NIU); EYS- …
  • Takeda Pharmaceuticals USA Inc-製薬・医療分野:企業M&A・提携分析
    Summary Takeda Pharmaceuticals USA Inc (TPUSA), formerly Takeda Pharmaceuticals North America Inc, a subsidiary of Takeda Pharmaceutical Company Ltd, is a developer, manufacturer and distributor of pharmaceutical drugs. The company’s products include pioglitazone and glimepiride, lubiprostone, piogl …
  • AptarGroup Inc:企業の戦略・SWOT・財務分析
    AptarGroup Inc - Strategy, SWOT and Corporate Finance Report Summary AptarGroup Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Community Health Systems Inc (CYH):企業の財務・戦略的SWOT分析
    Community Health Systems Inc (CYH) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Mizuno Corporation (8022):企業の財務・戦略的SWOT分析
    Mizuno Corporation (8022) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Chiyoda Corp (6366):企業の財務・戦略的SWOT分析
    Chiyoda Corp (6366) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Brodrene Hartmann A/S:企業の戦略・SWOT・財務情報
    Brodrene Hartmann A/S - Strategy, SWOT and Corporate Finance Report Summary Brodrene Hartmann A/S - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Audentes Therapeutics Inc (BOLD):企業の財務・戦略的SWOT分析
    Summary Audentes Therapeutics Inc (Audentes) is a biotechnology company. It focuses on the development and commercialization of gene therapy products for rare diseases. The company’s pipeline products include AT132, intended for the treatment of X-linked myotubular myopathy; AT982, for the treatment …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆